Scandi Standard (SCST) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
5 Feb, 2026Executive summary
Q4 2025 delivered 9% net sales growth and a 46% EBIT increase, driven by protein substitution trends, efficiency gains, and expansion in Europe.
Ready-to-Cook segment led growth and margin expansion, while Ready-to-Eat saw net sales growth but margin pressure from higher raw material costs; gradual recovery is underway.
Integration and ramp-up of acquisitions in Lithuania and the Netherlands are progressing as planned, supporting supply chain stability and capacity expansion.
Earnings per share rose 142% to SEK 1.47 in Q4, and a 32% higher dividend of SEK 3.30 per share is proposed.
Profitability and earnings improved significantly for both Q4 and the full year, reflecting operational improvements and market demand.
Financial highlights
Q4 2025 net sales reached MSEK 3,441 (up 9%); full year net sales were MSEK 14,083 (up 8%).
Q4 EBIT increased 46% to MSEK 156, with margin up to 4.5% from 3.4% last year; full year EBIT was MSEK 603 (up 18%).
Q4 EBITDA was MSEK 271 (margin 7.9%), and operating cash flow was MSEK 197.
Earnings per share for Q4 was SEK 1.47 (up 142%); full year EPS was SEK 5.61 (up 33%).
Net interest-bearing debt/EBITDA improved to 1.9x, below the internal target of 2.5x.
Outlook and guidance
Strong organic growth and margin improvement expected to continue in 2026, with a 2027 target of 5–7% organic net sales growth and EBIT margin above 6%.
Investments in 2026 projected at SEK 650 million, focused on capacity expansion and efficiency improvements in Lithuania and the Netherlands.
Dividend increase reflects confidence in future cash flow and earnings.
Management expects strong financial development in 2026, supported by high demand and operational improvements.
Latest events from Scandi Standard
- Q2 EBIT rose 5% to SEK 127m, margin hit 3.8%, driven by Ready-to-Cook and efficiency gains.SCST
Q2 20243 Feb 2026 - Adjusted EBIT up 18% with margin gains and Lithuanian acquisition boosting future growth.SCST
Q3 202418 Jan 2026 - Sales and EBIT rose, with acquisitions and investments driving future growth.SCST
Q1 202523 Dec 2025 - Record Q4 sales and EBIT, with acquisitions and higher dividend supporting future growth.SCST
Q4 202423 Dec 2025 - Record EBIT and 6% sales growth in Q2, with strong demand and positive Lithuania ramp-up.SCST
Q2 202516 Nov 2025 - Record EBIT and 11% sales growth, led by Ready-to-Cook and new market expansion.SCST
Q3 202523 Oct 2025